Your browser doesn't support javascript.
loading
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Yun-Bin LEE; Jeong-Hoon LEE.
Clinical and Molecular Hepatology ; : 219-221, 2017.
Article in En | WPRIM | ID: wpr-219274
Responsible library: WPRO
ABSTRACT
No abstract available.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
Search on Google
Full text: 1 Index: WPRIM Main subject: Hepatitis B virus / Drug Resistance, Multiple / Hepatitis B, Chronic / Tenofovir / Hepatitis / Hepatitis B Language: En Journal: Clinical and Molecular Hepatology Year: 2017 Type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google
Full text: 1 Index: WPRIM Main subject: Hepatitis B virus / Drug Resistance, Multiple / Hepatitis B, Chronic / Tenofovir / Hepatitis / Hepatitis B Language: En Journal: Clinical and Molecular Hepatology Year: 2017 Type: Article